IBEX WEALTH ADVISORS

Position in GILD — Gilead Sciences, Inc.

CIK 1686242 BEDMINSTER, NJ

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,984,927

-$150,639 QoQ

Shares Held

15,711

+2.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#836

of 2,266 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

IBEX WEALTH ADVISORS holds $67,705,763 across 7 Drug Manufacturers - General names. GILD ranks #6 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	63,424	$15,960,015
2	LLY	ELI LILLY & Co	12,208	$14,642,642
3	MRK	Merck & Co., Inc.	103,751	$13,332,003
4	AMGN	Amgen Inc	31,655	$11,462,908
5	PFE	Pfizer Inc	389,557	$9,380,532
6	GILD	Gilead Sciences, Inc. This page	15,711	$1,984,927
7	JNJ	Johnson & Johnson	3,712	$942,736

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,984,927	15,711	+2.5%	Shares	Sole	2026-07-27
2026-03-31	$2,135,566	15,323	-77.6%	Shares	Sole	2026-04-30
2025-12-31	$8,414,317	68,554	+390.1%	Shares	Sole	2026-02-17
2025-09-30	$1,552,668	13,988	+10.4%	Shares	Sole	2025-11-12
2025-06-30	$1,404,722	12,670	+36100.0%	Shares	Sole	2025-08-07
2024-06-30	$2,401	35	-99.9%	Shares	Sole	2024-08-06
2024-03-31	$5,620	65,468	+103817.5%	Shares	Sole	2024-04-18
2023-12-31	$5,103	63	-99.9%	Shares	Sole	2024-01-29
2023-09-30	$4,662,167	62,212	-6.9%	Shares	Sole	2023-11-07
2023-03-31	$5,546,378	66,848	+2.1%	Shares	Sole	2023-05-15
2022-12-31	$5,620,427	65,468	+0.7%	Shares	Sole	2023-02-06
2022-09-30	$4,011,700	65,030	-0.2%	Shares	Sole	2022-10-31
2022-06-30	$4,028,095	65,169	+486.0%	Shares	Sole	2022-08-16
2022-03-31	$661,143	11,121	-58.4%	Shares	Sole	2022-05-16
2020-03-31	$1,998,035	26,726	—	Shares	Sole	2020-05-05
No filing history on record for this holder in this stock.